IMM-BCP-01, a patient-derived anti–SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Anna N. Honko Michael S. Diamond Anthony Griffiths Nadia Storm Pavel A Nikitin |
| Publication date | September 9, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |